nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMP—Capecitabine—kidney cancer	0.312	0.526	CbGbCtD
Floxuridine—Decitabine—Gemcitabine—kidney cancer	0.248	1	CrCrCtD
Floxuridine—TYMS—Capecitabine—kidney cancer	0.166	0.28	CbGbCtD
Floxuridine—TYMS—Gemcitabine—kidney cancer	0.115	0.194	CbGbCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00332	0.102	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—DAPK1—kidney cancer	0.00225	0.0693	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—PPAT—kidney cancer	0.0017	0.0523	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—PPAT—kidney cancer	0.00167	0.0514	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—APRT—kidney cancer	0.00155	0.0478	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00149	0.0458	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—TFE3—kidney cancer	0.000939	0.0289	CbGpPWpGaD
Floxuridine—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.000913	0.27	CbGdCrCtD
Floxuridine—TYMS—Nucleotide metabolism—PPAT—kidney cancer	0.000854	0.0263	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—APRT—kidney cancer	0.000794	0.0244	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—BRAF—kidney cancer	0.000721	0.0222	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDH1—kidney cancer	0.000706	0.0217	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—kidney cancer	0.000623	0.0192	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—ERBB2—kidney cancer	0.000596	0.0183	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CCND1—kidney cancer	0.000526	0.0162	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—APAF1—kidney cancer	0.000507	0.0156	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—VEGFA—kidney cancer	0.000459	0.0141	CbGpPWpGaD
Floxuridine—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000439	0.13	CbGdCrCtD
Floxuridine—TYMS—Sirolimus—Everolimus—kidney cancer	0.000439	0.13	CbGdCrCtD
Floxuridine—TYMS—Gefitinib—Erlotinib—kidney cancer	0.000437	0.129	CbGdCrCtD
Floxuridine—TYMP—Bladder Cancer—MYC—kidney cancer	0.000422	0.013	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MAPK1—kidney cancer	0.000413	0.0127	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—TP53—kidney cancer	0.000347	0.0107	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—kidney cancer	0.00033	0.0101	CbGpPWpGaD
Floxuridine—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000293	0.0866	CbGdCrCtD
Floxuridine—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000293	0.0866	CbGdCrCtD
Floxuridine—TYMS—G1/S Transition—PSMD7—kidney cancer	0.000279	0.00858	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—SYNE2—kidney cancer	0.00026	0.00802	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—HNF1B—kidney cancer	0.000258	0.00794	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—KCNMA1—kidney cancer	0.000251	0.00774	CbGpPWpGaD
Floxuridine—TYMS—Vincristine—Vinblastine—kidney cancer	0.000251	0.074	CbGdCrCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000235	0.00723	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000235	0.00723	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000235	0.00723	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—JUND—kidney cancer	0.000225	0.00694	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000223	0.00685	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ACY1—kidney cancer	0.000219	0.00673	CbGpPWpGaD
Floxuridine—TYMS—Vinblastine—Vincristine—kidney cancer	0.000201	0.0595	CbGdCrCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000194	0.00596	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PDHB—kidney cancer	0.000186	0.00572	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000178	0.00548	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Dactinomycin—kidney cancer	0.000176	0.00143	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—kidney cancer	0.000175	0.00143	CcSEcCtD
Floxuridine—TYMP—Metabolism—CCBL1—kidney cancer	0.000175	0.00538	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000172	0.00529	CbGpPWpGaD
Floxuridine—Alopecia—Vincristine—kidney cancer	0.000172	0.0014	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—kidney cancer	0.000171	0.00139	CcSEcCtD
Floxuridine—Decreased appetite—Vinblastine—kidney cancer	0.00017	0.00139	CcSEcCtD
Floxuridine—Decreased appetite—Everolimus—kidney cancer	0.00017	0.00138	CcSEcCtD
Floxuridine—Anaphylactic shock—Sorafenib—kidney cancer	0.00017	0.00138	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—kidney cancer	0.000169	0.00138	CcSEcCtD
Floxuridine—Diarrhoea—Pazopanib—kidney cancer	0.000169	0.00138	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—kidney cancer	0.000169	0.00519	CbGpPWpGaD
Floxuridine—Infection—Sorafenib—kidney cancer	0.000168	0.00137	CcSEcCtD
Floxuridine—Dry skin—Capecitabine—kidney cancer	0.000168	0.00137	CcSEcCtD
Floxuridine—Stomatitis—Paclitaxel—kidney cancer	0.000168	0.00136	CcSEcCtD
Floxuridine—Vomiting—Temsirolimus—kidney cancer	0.000167	0.00136	CcSEcCtD
Floxuridine—Nervous system disorder—Sorafenib—kidney cancer	0.000166	0.00135	CcSEcCtD
Floxuridine—Thrombocytopenia—Sorafenib—kidney cancer	0.000166	0.00135	CcSEcCtD
Floxuridine—Rash—Temsirolimus—kidney cancer	0.000166	0.00135	CcSEcCtD
Floxuridine—Dermatitis—Temsirolimus—kidney cancer	0.000165	0.00135	CcSEcCtD
Floxuridine—Headache—Temsirolimus—kidney cancer	0.000164	0.00134	CcSEcCtD
Floxuridine—Decreased appetite—Erlotinib—kidney cancer	0.000164	0.00133	CcSEcCtD
Floxuridine—Alopecia—Gemcitabine—kidney cancer	0.000163	0.00133	CcSEcCtD
Floxuridine—Epistaxis—Paclitaxel—kidney cancer	0.000162	0.00132	CcSEcCtD
Floxuridine—Infection—Sunitinib—kidney cancer	0.000162	0.00132	CcSEcCtD
Floxuridine—Gastritis—Capecitabine—kidney cancer	0.000162	0.00132	CcSEcCtD
Floxuridine—Anorexia—Sorafenib—kidney cancer	0.000162	0.00132	CcSEcCtD
Floxuridine—Feeling abnormal—Vinblastine—kidney cancer	0.000162	0.00132	CcSEcCtD
Floxuridine—Feeling abnormal—Everolimus—kidney cancer	0.000161	0.00131	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—kidney cancer	0.000161	0.00494	CbGpPWpGaD
Floxuridine—Erythema—Gemcitabine—kidney cancer	0.00016	0.00131	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vinblastine—kidney cancer	0.00016	0.00131	CcSEcCtD
Floxuridine—Nervous system disorder—Sunitinib—kidney cancer	0.00016	0.0013	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.00016	0.00492	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.00016	0.00492	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Sunitinib—kidney cancer	0.00016	0.0013	CcSEcCtD
Floxuridine—Gastrointestinal pain—Everolimus—kidney cancer	0.00016	0.0013	CcSEcCtD
Floxuridine—Discomfort—Dactinomycin—kidney cancer	0.000159	0.0013	CcSEcCtD
Floxuridine—Vomiting—Pazopanib—kidney cancer	0.000157	0.00128	CcSEcCtD
Floxuridine—Anaemia—Vincristine—kidney cancer	0.000156	0.00127	CcSEcCtD
Floxuridine—Rash—Pazopanib—kidney cancer	0.000156	0.00127	CcSEcCtD
Floxuridine—Nausea—Temsirolimus—kidney cancer	0.000156	0.00127	CcSEcCtD
Floxuridine—Dermatitis—Pazopanib—kidney cancer	0.000156	0.00127	CcSEcCtD
Floxuridine—Anorexia—Sunitinib—kidney cancer	0.000156	0.00127	CcSEcCtD
Floxuridine—Haemoglobin—Paclitaxel—kidney cancer	0.000155	0.00126	CcSEcCtD
Floxuridine—Abdominal pain—Vinblastine—kidney cancer	0.000155	0.00126	CcSEcCtD
Floxuridine—Headache—Pazopanib—kidney cancer	0.000155	0.00126	CcSEcCtD
Floxuridine—Body temperature increased—Everolimus—kidney cancer	0.000154	0.00126	CcSEcCtD
Floxuridine—Abdominal pain—Everolimus—kidney cancer	0.000154	0.00126	CcSEcCtD
Floxuridine—Haemorrhage—Paclitaxel—kidney cancer	0.000154	0.00126	CcSEcCtD
Floxuridine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000154	0.00126	CcSEcCtD
Floxuridine—Angina pectoris—Capecitabine—kidney cancer	0.000154	0.00126	CcSEcCtD
Floxuridine—Infection—Dactinomycin—kidney cancer	0.000153	0.00125	CcSEcCtD
Floxuridine—Pharyngitis—Paclitaxel—kidney cancer	0.000153	0.00125	CcSEcCtD
Floxuridine—TYMP—Metabolism—GLIPR1—kidney cancer	0.000152	0.00467	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPAT—kidney cancer	0.000152	0.00467	CbGpPWpGaD
Floxuridine—Leukopenia—Vincristine—kidney cancer	0.000151	0.00123	CcSEcCtD
Floxuridine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000151	0.00123	CcSEcCtD
Floxuridine—Pancytopenia—Capecitabine—kidney cancer	0.00015	0.00122	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000149	0.0046	CbGpPWpGaD
Floxuridine—Abdominal pain—Erlotinib—kidney cancer	0.000149	0.00121	CcSEcCtD
Floxuridine—Body temperature increased—Erlotinib—kidney cancer	0.000149	0.00121	CcSEcCtD
Floxuridine—Ill-defined disorder—Gemcitabine—kidney cancer	0.000149	0.00121	CcSEcCtD
Floxuridine—Anaemia—Gemcitabine—kidney cancer	0.000148	0.00121	CcSEcCtD
Floxuridine—Rash maculo-papular—Doxorubicin—kidney cancer	0.000148	0.0012	CcSEcCtD
Floxuridine—Decreased appetite—Sorafenib—kidney cancer	0.000147	0.0012	CcSEcCtD
Floxuridine—Anorexia—Dactinomycin—kidney cancer	0.000147	0.0012	CcSEcCtD
Floxuridine—Nausea—Pazopanib—kidney cancer	0.000147	0.0012	CcSEcCtD
Floxuridine—Malaise—Gemcitabine—kidney cancer	0.000145	0.00118	CcSEcCtD
Floxuridine—Hypersensitivity—Vinblastine—kidney cancer	0.000144	0.00118	CcSEcCtD
Floxuridine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000144	0.00118	CcSEcCtD
Floxuridine—Hypersensitivity—Everolimus—kidney cancer	0.000144	0.00117	CcSEcCtD
Floxuridine—Leukopenia—Gemcitabine—kidney cancer	0.000144	0.00117	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EGR1—kidney cancer	0.000143	0.00442	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN1B—kidney cancer	0.000142	0.00438	CbGpPWpGaD
Floxuridine—Decreased appetite—Sunitinib—kidney cancer	0.000142	0.00116	CcSEcCtD
Floxuridine—TYMP—Metabolism—APRT—kidney cancer	0.000141	0.00434	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—FH—kidney cancer	0.000141	0.00434	CbGpPWpGaD
Floxuridine—Asthenia—Vinblastine—kidney cancer	0.000141	0.00115	CcSEcCtD
Floxuridine—Asthenia—Everolimus—kidney cancer	0.00014	0.00114	CcSEcCtD
Floxuridine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000139	0.00113	CcSEcCtD
Floxuridine—Anaphylactic shock—Vincristine—kidney cancer	0.000138	0.00112	CcSEcCtD
Floxuridine—Stomatitis—Capecitabine—kidney cancer	0.000137	0.00112	CcSEcCtD
Floxuridine—Infection—Vincristine—kidney cancer	0.000137	0.00112	CcSEcCtD
Floxuridine—Alopecia—Paclitaxel—kidney cancer	0.000136	0.00111	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—kidney cancer	0.000136	0.00111	CcSEcCtD
Floxuridine—Nervous system disorder—Vincristine—kidney cancer	0.000135	0.0011	CcSEcCtD
Floxuridine—Asthenia—Erlotinib—kidney cancer	0.000135	0.0011	CcSEcCtD
Floxuridine—Thrombocytopenia—Vincristine—kidney cancer	0.000135	0.0011	CcSEcCtD
Floxuridine—Discomfort—Gemcitabine—kidney cancer	0.000135	0.0011	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000135	0.00415	CbGpPWpGaD
Floxuridine—Photosensitivity—Doxorubicin—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Erythema—Paclitaxel—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Diarrhoea—Vinblastine—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Abdominal pain—Sorafenib—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Body temperature increased—Sorafenib—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Diarrhoea—Everolimus—kidney cancer	0.000134	0.00109	CcSEcCtD
Floxuridine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000133	0.00109	CcSEcCtD
Floxuridine—Epistaxis—Capecitabine—kidney cancer	0.000133	0.00108	CcSEcCtD
Floxuridine—TYMP—Metabolism—GPC3—kidney cancer	0.000133	0.00408	CbGpPWpGaD
Floxuridine—Agranulocytosis—Capecitabine—kidney cancer	0.000132	0.00107	CcSEcCtD
Floxuridine—Anorexia—Vincristine—kidney cancer	0.000132	0.00107	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000131	0.00404	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000131	0.00107	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.00013	0.004	CbGpPWpGaD
Floxuridine—Infection—Gemcitabine—kidney cancer	0.00013	0.00106	CcSEcCtD
Floxuridine—Muscle spasms—Paclitaxel—kidney cancer	0.000129	0.00105	CcSEcCtD
Floxuridine—Body temperature increased—Sunitinib—kidney cancer	0.000129	0.00105	CcSEcCtD
Floxuridine—Abdominal pain—Sunitinib—kidney cancer	0.000129	0.00105	CcSEcCtD
Floxuridine—Diarrhoea—Erlotinib—kidney cancer	0.000129	0.00105	CcSEcCtD
Floxuridine—TYMP—Metabolism—CA2—kidney cancer	0.000129	0.00397	CbGpPWpGaD
Floxuridine—Nervous system disorder—Gemcitabine—kidney cancer	0.000128	0.00105	CcSEcCtD
Floxuridine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000128	0.00104	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—kidney cancer	0.000127	0.00104	CcSEcCtD
Floxuridine—Haemoglobin—Capecitabine—kidney cancer	0.000127	0.00104	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000127	0.00391	CbGpPWpGaD
Floxuridine—Haemorrhage—Capecitabine—kidney cancer	0.000127	0.00103	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000126	0.00103	CcSEcCtD
Floxuridine—Pharyngitis—Capecitabine—kidney cancer	0.000126	0.00102	CcSEcCtD
Floxuridine—TYMP—Metabolism—ALAD—kidney cancer	0.000126	0.00387	CbGpPWpGaD
Floxuridine—Hypersensitivity—Sorafenib—kidney cancer	0.000125	0.00102	CcSEcCtD
Floxuridine—Anorexia—Gemcitabine—kidney cancer	0.000125	0.00102	CcSEcCtD
Floxuridine—Vomiting—Vinblastine—kidney cancer	0.000125	0.00102	CcSEcCtD
Floxuridine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000125	0.00102	CcSEcCtD
Floxuridine—Vomiting—Everolimus—kidney cancer	0.000124	0.00101	CcSEcCtD
Floxuridine—Anaemia—Paclitaxel—kidney cancer	0.000124	0.00101	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000124	0.0038	CbGpPWpGaD
Floxuridine—Rash—Everolimus—kidney cancer	0.000123	0.001	CcSEcCtD
Floxuridine—Dermatitis—Everolimus—kidney cancer	0.000123	0.001	CcSEcCtD
Floxuridine—Headache—Vinblastine—kidney cancer	0.000123	0.001	CcSEcCtD
Floxuridine—TYMP—Metabolism—ST3GAL2—kidney cancer	0.000123	0.00377	CbGpPWpGaD
Floxuridine—Headache—Everolimus—kidney cancer	0.000122	0.000997	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—kidney cancer	0.000122	0.000995	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—kidney cancer	0.000122	0.000995	CcSEcCtD
Floxuridine—Asthenia—Sorafenib—kidney cancer	0.000122	0.000991	CcSEcCtD
Floxuridine—Malaise—Paclitaxel—kidney cancer	0.000121	0.000987	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—kidney cancer	0.00012	0.000981	CcSEcCtD
Floxuridine—Leukopenia—Paclitaxel—kidney cancer	0.00012	0.00098	CcSEcCtD
Floxuridine—Hypersensitivity—Sunitinib—kidney cancer	0.00012	0.000979	CcSEcCtD
Floxuridine—Decreased appetite—Vincristine—kidney cancer	0.00012	0.000977	CcSEcCtD
Floxuridine—TYMP—Metabolism—ALDH1A1—kidney cancer	0.00012	0.00369	CbGpPWpGaD
Floxuridine—Vomiting—Erlotinib—kidney cancer	0.00012	0.000976	CcSEcCtD
Floxuridine—Rash—Erlotinib—kidney cancer	0.000119	0.000968	CcSEcCtD
Floxuridine—Dermatitis—Erlotinib—kidney cancer	0.000119	0.000967	CcSEcCtD
Floxuridine—Headache—Erlotinib—kidney cancer	0.000118	0.000962	CcSEcCtD
Floxuridine—TYMS—Azacitidine—Gemcitabine—kidney cancer	0.000118	0.0349	CbGdCrCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000118	0.00363	CbGpPWpGaD
Floxuridine—Asthenia—Sunitinib—kidney cancer	0.000117	0.000954	CcSEcCtD
Floxuridine—Nausea—Vinblastine—kidney cancer	0.000116	0.000949	CcSEcCtD
Floxuridine—Nausea—Everolimus—kidney cancer	0.000116	0.000945	CcSEcCtD
Floxuridine—Diarrhoea—Sorafenib—kidney cancer	0.000116	0.000945	CcSEcCtD
Floxuridine—TYMP—Metabolism—PGK1—kidney cancer	0.000115	0.00354	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC5A3—kidney cancer	0.000115	0.00354	CbGpPWpGaD
Floxuridine—Decreased appetite—Gemcitabine—kidney cancer	0.000114	0.000927	CcSEcCtD
Floxuridine—Hypersensitivity—Dactinomycin—kidney cancer	0.000114	0.000927	CcSEcCtD
Floxuridine—Discomfort—Paclitaxel—kidney cancer	0.000113	0.00092	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vincristine—kidney cancer	0.000113	0.000919	CcSEcCtD
Floxuridine—TYMP—Metabolism—LDHB—kidney cancer	0.000113	0.00347	CbGpPWpGaD
Floxuridine—Nausea—Erlotinib—kidney cancer	0.000112	0.000912	CcSEcCtD
Floxuridine—TYMS—Metabolism—ACY1—kidney cancer	0.000112	0.00344	CbGpPWpGaD
Floxuridine—Alopecia—Capecitabine—kidney cancer	0.000112	0.000912	CcSEcCtD
Floxuridine—Diarrhoea—Sunitinib—kidney cancer	0.000112	0.00091	CcSEcCtD
Floxuridine—Asthenia—Dactinomycin—kidney cancer	0.000111	0.000903	CcSEcCtD
Floxuridine—Confusional state—Paclitaxel—kidney cancer	0.000111	0.000901	CcSEcCtD
Floxuridine—Erythema—Capecitabine—kidney cancer	0.00011	0.000898	CcSEcCtD
Floxuridine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00011	0.000893	CcSEcCtD
Floxuridine—Abdominal pain—Vincristine—kidney cancer	0.000109	0.000889	CcSEcCtD
Floxuridine—Body temperature increased—Vincristine—kidney cancer	0.000109	0.000889	CcSEcCtD
Floxuridine—Infection—Paclitaxel—kidney cancer	0.000109	0.000887	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—kidney cancer	0.000109	0.00335	CbGpPWpGaD
Floxuridine—Dry skin—Doxorubicin—kidney cancer	0.000108	0.000881	CcSEcCtD
Floxuridine—Feeling abnormal—Gemcitabine—kidney cancer	0.000108	0.000879	CcSEcCtD
Floxuridine—Vomiting—Sorafenib—kidney cancer	0.000108	0.000878	CcSEcCtD
Floxuridine—Nervous system disorder—Paclitaxel—kidney cancer	0.000107	0.000876	CcSEcCtD
Floxuridine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000107	0.000874	CcSEcCtD
Floxuridine—Rash—Sorafenib—kidney cancer	0.000107	0.000871	CcSEcCtD
Floxuridine—Dermatitis—Sorafenib—kidney cancer	0.000107	0.00087	CcSEcCtD
Floxuridine—Headache—Sorafenib—kidney cancer	0.000106	0.000866	CcSEcCtD
Floxuridine—Muscle spasms—Capecitabine—kidney cancer	0.000106	0.000863	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—kidney cancer	0.000106	0.000861	CcSEcCtD
Floxuridine—Anorexia—Paclitaxel—kidney cancer	0.000104	0.000851	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—kidney cancer	0.000104	0.000851	CcSEcCtD
Floxuridine—Vomiting—Sunitinib—kidney cancer	0.000104	0.000845	CcSEcCtD
Floxuridine—Body temperature increased—Gemcitabine—kidney cancer	0.000103	0.000843	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1B—kidney cancer	0.000103	0.00318	CbGpPWpGaD
Floxuridine—Rash—Sunitinib—kidney cancer	0.000103	0.000838	CcSEcCtD
Floxuridine—Dermatitis—Sunitinib—kidney cancer	0.000103	0.000837	CcSEcCtD
Floxuridine—Ill-defined disorder—Capecitabine—kidney cancer	0.000102	0.000833	CcSEcCtD
Floxuridine—Headache—Sunitinib—kidney cancer	0.000102	0.000833	CcSEcCtD
Floxuridine—Anaemia—Capecitabine—kidney cancer	0.000102	0.00083	CcSEcCtD
Floxuridine—Hypersensitivity—Vincristine—kidney cancer	0.000102	0.000828	CcSEcCtD
Floxuridine—Nausea—Sorafenib—kidney cancer	0.000101	0.000821	CcSEcCtD
Floxuridine—Malaise—Capecitabine—kidney cancer	9.94e-05	0.00081	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—kidney cancer	9.93e-05	0.000809	CcSEcCtD
Floxuridine—Asthenia—Vincristine—kidney cancer	9.9e-05	0.000807	CcSEcCtD
Floxuridine—Leukopenia—Capecitabine—kidney cancer	9.86e-05	0.000804	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—kidney cancer	9.82e-05	0.0008	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	9.82e-05	0.00302	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CA9—kidney cancer	9.77e-05	0.00301	CbGpPWpGaD
Floxuridine—Rash—Dactinomycin—kidney cancer	9.74e-05	0.000794	CcSEcCtD
Floxuridine—Nausea—Sunitinib—kidney cancer	9.69e-05	0.00079	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—kidney cancer	9.68e-05	0.000789	CcSEcCtD
Floxuridine—Decreased appetite—Paclitaxel—kidney cancer	9.53e-05	0.000776	CcSEcCtD
Floxuridine—TYMS—Metabolism—PDHB—kidney cancer	9.51e-05	0.00293	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	9.46e-05	0.00291	CbGpPWpGaD
Floxuridine—Diarrhoea—Vincristine—kidney cancer	9.44e-05	0.000769	CcSEcCtD
Floxuridine—Asthenia—Gemcitabine—kidney cancer	9.39e-05	0.000765	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—kidney cancer	9.31e-05	0.000758	CcSEcCtD
Floxuridine—Discomfort—Capecitabine—kidney cancer	9.27e-05	0.000755	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—kidney cancer	9.17e-05	0.000748	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	9.16e-05	0.00282	CbGpPWpGaD
Floxuridine—Confusional state—Capecitabine—kidney cancer	9.07e-05	0.000739	CcSEcCtD
Floxuridine—Feeling abnormal—Paclitaxel—kidney cancer	9.03e-05	0.000736	CcSEcCtD
Floxuridine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.96e-05	0.00073	CcSEcCtD
Floxuridine—Diarrhoea—Gemcitabine—kidney cancer	8.96e-05	0.00073	CcSEcCtD
Floxuridine—TYMS—Metabolism—CCBL1—kidney cancer	8.94e-05	0.00275	CbGpPWpGaD
Floxuridine—Infection—Capecitabine—kidney cancer	8.94e-05	0.000728	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—kidney cancer	8.86e-05	0.000722	CcSEcCtD
Floxuridine—Nervous system disorder—Capecitabine—kidney cancer	8.82e-05	0.000719	CcSEcCtD
Floxuridine—Thrombocytopenia—Capecitabine—kidney cancer	8.81e-05	0.000718	CcSEcCtD
Floxuridine—Vomiting—Vincristine—kidney cancer	8.77e-05	0.000715	CcSEcCtD
Floxuridine—Rash—Vincristine—kidney cancer	8.7e-05	0.000709	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	8.7e-05	0.00268	CbGpPWpGaD
Floxuridine—Dermatitis—Vincristine—kidney cancer	8.69e-05	0.000708	CcSEcCtD
Floxuridine—Abdominal pain—Paclitaxel—kidney cancer	8.66e-05	0.000706	CcSEcCtD
Floxuridine—Body temperature increased—Paclitaxel—kidney cancer	8.66e-05	0.000706	CcSEcCtD
Floxuridine—Headache—Vincristine—kidney cancer	8.64e-05	0.000704	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—PSMD7—kidney cancer	8.62e-05	0.00265	CbGpPWpGaD
Floxuridine—Epistaxis—Doxorubicin—kidney cancer	8.57e-05	0.000699	CcSEcCtD
Floxuridine—Anorexia—Capecitabine—kidney cancer	8.57e-05	0.000699	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—kidney cancer	8.48e-05	0.000691	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—AURKA—kidney cancer	8.38e-05	0.00258	CbGpPWpGaD
Floxuridine—Vomiting—Gemcitabine—kidney cancer	8.32e-05	0.000678	CcSEcCtD
Floxuridine—TYMP—Metabolism—CRABP1—kidney cancer	8.31e-05	0.00256	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—kidney cancer	8.3e-05	0.00255	CbGpPWpGaD
Floxuridine—Rash—Gemcitabine—kidney cancer	8.25e-05	0.000673	CcSEcCtD
Floxuridine—Dermatitis—Gemcitabine—kidney cancer	8.25e-05	0.000672	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—kidney cancer	8.2e-05	0.000668	CcSEcCtD
Floxuridine—Headache—Gemcitabine—kidney cancer	8.2e-05	0.000668	CcSEcCtD
Floxuridine—Nausea—Vincristine—kidney cancer	8.2e-05	0.000668	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—kidney cancer	8.16e-05	0.000665	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—kidney cancer	8.1e-05	0.00066	CcSEcCtD
Floxuridine—Hypersensitivity—Paclitaxel—kidney cancer	8.07e-05	0.000658	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—MYC—kidney cancer	7.9e-05	0.00243	CbGpPWpGaD
Floxuridine—Asthenia—Paclitaxel—kidney cancer	7.86e-05	0.000641	CcSEcCtD
Floxuridine—Decreased appetite—Capecitabine—kidney cancer	7.82e-05	0.000637	CcSEcCtD
Floxuridine—Nausea—Gemcitabine—kidney cancer	7.78e-05	0.000634	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	7.77e-05	0.00239	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPAT—kidney cancer	7.76e-05	0.00239	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GLIPR1—kidney cancer	7.76e-05	0.00239	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ITPR2—kidney cancer	7.72e-05	0.00238	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—PSMD7—kidney cancer	7.71e-05	0.00237	CbGpPWpGaD
Floxuridine—Diarrhoea—Paclitaxel—kidney cancer	7.5e-05	0.000611	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—AURKA—kidney cancer	7.5e-05	0.00231	CbGpPWpGaD
Floxuridine—Feeling abnormal—Capecitabine—kidney cancer	7.41e-05	0.000604	CcSEcCtD
Floxuridine—Gastrointestinal pain—Capecitabine—kidney cancer	7.35e-05	0.000599	CcSEcCtD
Floxuridine—Alopecia—Doxorubicin—kidney cancer	7.21e-05	0.000588	CcSEcCtD
Floxuridine—TYMS—Metabolism—APRT—kidney cancer	7.21e-05	0.00222	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—FH—kidney cancer	7.21e-05	0.00222	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	7.19e-05	0.00221	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	7.11e-05	0.00219	CbGpPWpGaD
Floxuridine—Abdominal pain—Capecitabine—kidney cancer	7.11e-05	0.000579	CcSEcCtD
Floxuridine—Body temperature increased—Capecitabine—kidney cancer	7.11e-05	0.000579	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—kidney cancer	7.1e-05	0.000579	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTT1—kidney cancer	7.04e-05	0.00217	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ACHE—kidney cancer	7.04e-05	0.00217	CbGpPWpGaD
Floxuridine—Vomiting—Paclitaxel—kidney cancer	6.97e-05	0.000568	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.96e-05	0.00214	CbGpPWpGaD
Floxuridine—Rash—Paclitaxel—kidney cancer	6.91e-05	0.000563	CcSEcCtD
Floxuridine—Dermatitis—Paclitaxel—kidney cancer	6.9e-05	0.000563	CcSEcCtD
Floxuridine—Headache—Paclitaxel—kidney cancer	6.87e-05	0.000559	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—kidney cancer	6.83e-05	0.000557	CcSEcCtD
Floxuridine—TYMS—Metabolism—GPC3—kidney cancer	6.78e-05	0.00209	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SCARB1—kidney cancer	6.67e-05	0.00205	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—kidney cancer	6.65e-05	0.00205	CbGpPWpGaD
Floxuridine—Hypersensitivity—Capecitabine—kidney cancer	6.63e-05	0.00054	CcSEcCtD
Floxuridine—TYMP—Metabolism—PTGS1—kidney cancer	6.6e-05	0.00203	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CA2—kidney cancer	6.59e-05	0.00203	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Doxorubicin—kidney cancer	6.59e-05	0.000537	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.59e-05	0.00203	CbGpPWpGaD
Floxuridine—Anaemia—Doxorubicin—kidney cancer	6.57e-05	0.000535	CcSEcCtD
Floxuridine—Nausea—Paclitaxel—kidney cancer	6.51e-05	0.00053	CcSEcCtD
Floxuridine—TYMP—Metabolism—PSMD7—kidney cancer	6.47e-05	0.00199	CbGpPWpGaD
Floxuridine—Asthenia—Capecitabine—kidney cancer	6.45e-05	0.000526	CcSEcCtD
Floxuridine—TYMS—Metabolism—ALAD—kidney cancer	6.43e-05	0.00198	CbGpPWpGaD
Floxuridine—Malaise—Doxorubicin—kidney cancer	6.41e-05	0.000522	CcSEcCtD
Floxuridine—Leukopenia—Doxorubicin—kidney cancer	6.36e-05	0.000518	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2B—kidney cancer	6.3e-05	0.00194	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.29e-05	0.00193	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ST3GAL2—kidney cancer	6.27e-05	0.00193	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.27e-05	0.00193	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.22e-05	0.00192	CbGpPWpGaD
Floxuridine—Diarrhoea—Capecitabine—kidney cancer	6.15e-05	0.000501	CcSEcCtD
Floxuridine—TYMP—Metabolism—BCHE—kidney cancer	6.13e-05	0.00189	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALDH1A1—kidney cancer	6.13e-05	0.00189	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.07e-05	0.00187	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC5A5—kidney cancer	6.06e-05	0.00187	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—JUN—kidney cancer	6.02e-05	0.00185	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—kidney cancer	5.98e-05	0.000487	CcSEcCtD
Floxuridine—TYMS—Metabolism—PGK1—kidney cancer	5.88e-05	0.00181	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC5A3—kidney cancer	5.88e-05	0.00181	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC2A1—kidney cancer	5.85e-05	0.0018	CbGpPWpGaD
Floxuridine—Confusional state—Doxorubicin—kidney cancer	5.85e-05	0.000476	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—kidney cancer	5.82e-05	0.00179	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Doxorubicin—kidney cancer	5.8e-05	0.000472	CcSEcCtD
Floxuridine—TYMS—Metabolism—LDHB—kidney cancer	5.76e-05	0.00177	CbGpPWpGaD
Floxuridine—Infection—Doxorubicin—kidney cancer	5.76e-05	0.000469	CcSEcCtD
Floxuridine—Vomiting—Capecitabine—kidney cancer	5.72e-05	0.000466	CcSEcCtD
Floxuridine—Nervous system disorder—Doxorubicin—kidney cancer	5.69e-05	0.000463	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BRCA2—kidney cancer	5.68e-05	0.00175	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Doxorubicin—kidney cancer	5.68e-05	0.000463	CcSEcCtD
Floxuridine—Rash—Capecitabine—kidney cancer	5.67e-05	0.000462	CcSEcCtD
Floxuridine—Dermatitis—Capecitabine—kidney cancer	5.67e-05	0.000462	CcSEcCtD
Floxuridine—Headache—Capecitabine—kidney cancer	5.63e-05	0.000459	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CDKN2B—kidney cancer	5.63e-05	0.00173	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—kidney cancer	5.53e-05	0.00045	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.48e-05	0.00169	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	5.43e-05	0.00167	CbGpPWpGaD
Floxuridine—Nausea—Capecitabine—kidney cancer	5.34e-05	0.000435	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.18e-05	0.0016	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.04e-05	0.00155	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—kidney cancer	5.04e-05	0.000411	CcSEcCtD
Floxuridine—TYMS—Metabolism—CA9—kidney cancer	5e-05	0.00154	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.93e-05	0.00152	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTP1—kidney cancer	4.88e-05	0.0015	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—BIRC5—kidney cancer	4.86e-05	0.0015	CbGpPWpGaD
Floxuridine—Feeling abnormal—Doxorubicin—kidney cancer	4.78e-05	0.000389	CcSEcCtD
Floxuridine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.74e-05	0.000386	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.66e-05	0.00143	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—kidney cancer	4.62e-05	0.00142	CbGpPWpGaD
Floxuridine—Body temperature increased—Doxorubicin—kidney cancer	4.58e-05	0.000373	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—kidney cancer	4.58e-05	0.000373	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTM1—kidney cancer	4.49e-05	0.00138	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.28e-05	0.00132	CbGpPWpGaD
Floxuridine—Hypersensitivity—Doxorubicin—kidney cancer	4.27e-05	0.000348	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP1A1—kidney cancer	4.25e-05	0.00131	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CRABP1—kidney cancer	4.25e-05	0.00131	CbGpPWpGaD
Floxuridine—Asthenia—Doxorubicin—kidney cancer	4.16e-05	0.000339	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.14e-05	0.00127	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—kidney cancer	3.97e-05	0.00122	CbGpPWpGaD
Floxuridine—Diarrhoea—Doxorubicin—kidney cancer	3.97e-05	0.000323	CcSEcCtD
Floxuridine—TYMS—Metabolism—ITPR2—kidney cancer	3.95e-05	0.00122	CbGpPWpGaD
Floxuridine—Vomiting—Doxorubicin—kidney cancer	3.69e-05	0.0003	CcSEcCtD
Floxuridine—Rash—Doxorubicin—kidney cancer	3.66e-05	0.000298	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—kidney cancer	3.65e-05	0.000298	CcSEcCtD
Floxuridine—Headache—Doxorubicin—kidney cancer	3.63e-05	0.000296	CcSEcCtD
Floxuridine—TYMS—Metabolism—GSTT1—kidney cancer	3.6e-05	0.00111	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ACHE—kidney cancer	3.6e-05	0.00111	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.6e-05	0.00111	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—kidney cancer	3.44e-05	0.000281	CcSEcCtD
Floxuridine—TYMS—Metabolism—SCARB1—kidney cancer	3.41e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS1—kidney cancer	3.38e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PSMD7—kidney cancer	3.31e-05	0.00102	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2A—kidney cancer	3.22e-05	0.000991	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.19e-05	0.000982	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—POMC—kidney cancer	3.17e-05	0.000976	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—BCHE—kidney cancer	3.14e-05	0.000966	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC5A5—kidney cancer	3.1e-05	0.000954	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	3.04e-05	0.000937	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC2A1—kidney cancer	2.99e-05	0.000922	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1B—kidney cancer	2.85e-05	0.000878	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—kidney cancer	2.72e-05	0.000837	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—kidney cancer	2.53e-05	0.000778	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.51e-05	0.000772	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTP1—kidney cancer	2.5e-05	0.000769	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	2.44e-05	0.000751	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.39e-05	0.000735	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—kidney cancer	2.36e-05	0.000728	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM1—kidney cancer	2.29e-05	0.000706	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK3—kidney cancer	2.24e-05	0.000691	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—kidney cancer	2.21e-05	0.000679	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—kidney cancer	2.18e-05	0.000672	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1A1—kidney cancer	2.18e-05	0.00067	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK1—kidney cancer	2.13e-05	0.000657	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—kidney cancer	1.79e-05	0.000552	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—POMC—kidney cancer	1.62e-05	0.000499	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—kidney cancer	1.56e-05	0.000479	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—kidney cancer	1.29e-05	0.000398	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—kidney cancer	1.13e-05	0.000347	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—kidney cancer	7.96e-06	0.000245	CbGpPWpGaD
